Characteristics of immune cells and cytokines in patients with coronavirus disease 2019 in Guangzhou, China
العنوان: | Characteristics of immune cells and cytokines in patients with coronavirus disease 2019 in Guangzhou, China |
---|---|
المؤلفون: | Ying Huang, Jiabin Chen, Xiaowen Jiang, Yaling Shi, Jide Huang, Yingyi Huang, Xing Chen |
المصدر: | Human Immunology |
بيانات النشر: | Elsevier BV, 2020. |
سنة النشر: | 2020 |
مصطلحات موضوعية: | Male, 0301 basic medicine, G-CSF, Granulocyte colony-stimulating factor, Severity of Illness Index, T-Lymphocytes, Regulatory, Gastroenterology, MCP-1, Monocyte chemoattractant protein-1, 0302 clinical medicine, Immunology and Allergy, IL, Interleukin, IL-2 receptor, B-Lymphocytes, COVID-19, Coronavirus disease 2019, biology, Th1, T helper 1, Immune cells, EDTA, Ethylenediaminetetraacetic acid, General Medicine, Middle Aged, Prognosis, PBS, Phosphate-buffered saline, WBC, White blood cells, Interleukin-10, Up-Regulation, IFN, Interferon, Th2, T helper 2, Killer Cells, Natural, Interleukin 10, Cytokines, Female, medicine.symptom, Research Article, Adult, China, medicine.medical_specialty, MIP-1A, Macrophage inflammatory protein 1 alpha, Immunology, NKT cells, Natural killer T cells, Inflammation, Tregs, Regulatory T cells, macromolecular substances, 03 medical and health sciences, Immune system, Internal medicine, Severity of illness, medicine, Humans, Lymphocyte Count, Interleukin-7 receptor, Interleukin 6, Aged, Interleukin-6, SARS-CoV-2, business.industry, IP-10, Interferon gamma-induced protein 10, TNF, Tumor necrosis factor, COVID-19, NK cells, Natural killer cells, 030104 developmental biology, biology.protein, business, CD8, 030215 immunology |
الوصف: | To discover immune factors that can predict the progression of COVID-19, we evaluated circulating immune cells and plasma cytokines in COVID-19 patients. We found that T cells, including CD4+ T cells and CD8+ T cells, were significantly decreased in severe COVID-19 symptoms but not in mild symptoms, in comparison with healthy people. T cells remained at a low level after recovery from severe COVID-19. CD4+CD25+CD127low Treg-enriched cells were significantly increased in either mild or severe COVID-19 patients, regardless of recovery or not. Moreover, in either mild or severe COVID-19 patients, Treg-enriched cells up-regulated CD25 and down-regulated CD127. After recovery, CD25 was partially down-regulated but still higher than the normal level, while CD127 returned to the normal level in mild patients but not severe patients. B cells were decreased in mild patients and further decreased in severe patients, and remained low after recovery. NK cells were decreased only in severe COVID-19, with a tendency to return to the normal level after recovery. Plasma IL-6 and IL-10 were both elevated in severe patients but not in mild patients. After recovery, IL-6 remained higher than its normal level, while IL-10 returned to the normal level. Binary logistic regression analysis indicated that CD4+ T cells, B cells, IL-6, and IL-10 were significantly associated with COVID-19 severity. Therefore, these parameters are indicators of COVID-19 severity. Dynamic monitoring of these parameters would benefit therapy planning and prognosis evaluation. |
تدمد: | 0198-8859 |
الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3a70e9df0e9f88464b7539e60bc6d2cTest https://doi.org/10.1016/j.humimm.2020.08.006Test |
حقوق: | OPEN |
رقم الانضمام: | edsair.doi.dedup.....a3a70e9df0e9f88464b7539e60bc6d2c |
قاعدة البيانات: | OpenAIRE |
ResultId |
1 |
---|---|
Header |
edsair OpenAIRE edsair.doi.dedup.....a3a70e9df0e9f88464b7539e60bc6d2c 878 3 unknown 877.636657714844 |
PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a3a70e9df0e9f88464b7539e60bc6d2c&custid=s6537998&authtype=sso |
FullText |
Array
(
[Availability] => 0
)
|
Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => Characteristics of immune cells and cytokines in patients with coronavirus disease 2019 in Guangzhou, China
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Ying+Huang%22">Ying Huang</searchLink><br /><searchLink fieldCode="AR" term="%22Jiabin+Chen%22">Jiabin Chen</searchLink><br /><searchLink fieldCode="AR" term="%22Xiaowen+Jiang%22">Xiaowen Jiang</searchLink><br /><searchLink fieldCode="AR" term="%22Yaling+Shi%22">Yaling Shi</searchLink><br /><searchLink fieldCode="AR" term="%22Jide+Huang%22">Jide Huang</searchLink><br /><searchLink fieldCode="AR" term="%22Yingyi+Huang%22">Yingyi Huang</searchLink><br /><searchLink fieldCode="AR" term="%22Xing+Chen%22">Xing Chen</searchLink> ) Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => Human Immunology ) Array ( [Name] => Publisher [Label] => Publisher Information [Group] => PubInfo [Data] => Elsevier BV, 2020. ) Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2020 ) Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22Male%22">Male</searchLink><br /><searchLink fieldCode="DE" term="%220301+basic+medicine%22">0301 basic medicine</searchLink><br /><searchLink fieldCode="DE" term="%22G-CSF%2C+Granulocyte+colony-stimulating+factor%22">G-CSF, Granulocyte colony-stimulating factor</searchLink><br /><searchLink fieldCode="DE" term="%22Severity+of+Illness+Index%22">Severity of Illness Index</searchLink><br /><searchLink fieldCode="DE" term="%22T-Lymphocytes%2C+Regulatory%22">T-Lymphocytes, Regulatory</searchLink><br /><searchLink fieldCode="DE" term="%22Gastroenterology%22">Gastroenterology</searchLink><br /><searchLink fieldCode="DE" term="%22MCP-1%2C+Monocyte+chemoattractant+protein-1%22">MCP-1, Monocyte chemoattractant protein-1</searchLink><br /><searchLink fieldCode="DE" term="%220302+clinical+medicine%22">0302 clinical medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Immunology+and+Allergy%22">Immunology and Allergy</searchLink><br /><searchLink fieldCode="DE" term="%22IL%2C+Interleukin%22">IL, Interleukin</searchLink><br /><searchLink fieldCode="DE" term="%22IL-2+receptor%22">IL-2 receptor</searchLink><br /><searchLink fieldCode="DE" term="%22B-Lymphocytes%22">B-Lymphocytes</searchLink><br /><searchLink fieldCode="DE" term="%22COVID-19%2C+Coronavirus+disease+2019%22">COVID-19, Coronavirus disease 2019</searchLink><br /><searchLink fieldCode="DE" term="%22biology%22">biology</searchLink><br /><searchLink fieldCode="DE" term="%22Th1%2C+T+helper+1%22">Th1, T helper 1</searchLink><br /><searchLink fieldCode="DE" term="%22Immune+cells%22">Immune cells</searchLink><br /><searchLink fieldCode="DE" term="%22EDTA%2C+Ethylenediaminetetraacetic+acid%22">EDTA, Ethylenediaminetetraacetic acid</searchLink><br /><searchLink fieldCode="DE" term="%22General+Medicine%22">General Medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Middle+Aged%22">Middle Aged</searchLink><br /><searchLink fieldCode="DE" term="%22Prognosis%22">Prognosis</searchLink><br /><searchLink fieldCode="DE" term="%22PBS%2C+Phosphate-buffered+saline%22">PBS, Phosphate-buffered saline</searchLink><br /><searchLink fieldCode="DE" term="%22WBC%2C+White+blood+cells%22">WBC, White blood cells</searchLink><br /><searchLink fieldCode="DE" term="%22Interleukin-10%22">Interleukin-10</searchLink><br /><searchLink fieldCode="DE" term="%22Up-Regulation%22">Up-Regulation</searchLink><br /><searchLink fieldCode="DE" term="%22IFN%2C+Interferon%22">IFN, Interferon</searchLink><br /><searchLink fieldCode="DE" term="%22Th2%2C+T+helper+2%22">Th2, T helper 2</searchLink><br /><searchLink fieldCode="DE" term="%22Killer+Cells%2C+Natural%22">Killer Cells, Natural</searchLink><br /><searchLink fieldCode="DE" term="%22Interleukin+10%22">Interleukin 10</searchLink><br /><searchLink fieldCode="DE" term="%22Cytokines%22">Cytokines</searchLink><br /><searchLink fieldCode="DE" term="%22Female%22">Female</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%2Esymptom%22">medicine.symptom</searchLink><br /><searchLink fieldCode="DE" term="%22Research+Article%22">Research Article</searchLink><br /><searchLink fieldCode="DE" term="%22Adult%22">Adult</searchLink><br /><searchLink fieldCode="DE" term="%22China%22">China</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%2Emedical%5Fspecialty%22">medicine.medical_specialty</searchLink><br /><searchLink fieldCode="DE" term="%22MIP-1A%2C+Macrophage+inflammatory+protein+1+alpha%22">MIP-1A, Macrophage inflammatory protein 1 alpha</searchLink><br /><searchLink fieldCode="DE" term="%22Immunology%22">Immunology</searchLink><br /><searchLink fieldCode="DE" term="%22NKT+cells%2C+Natural+killer+T+cells%22">NKT cells, Natural killer T cells</searchLink><br /><searchLink fieldCode="DE" term="%22Inflammation%22">Inflammation</searchLink><br /><searchLink fieldCode="DE" term="%22Tregs%2C+Regulatory+T+cells%22">Tregs, Regulatory T cells</searchLink><br /><searchLink fieldCode="DE" term="%22macromolecular+substances%22">macromolecular substances</searchLink><br /><searchLink fieldCode="DE" term="%2203+medical+and+health+sciences%22">03 medical and health sciences</searchLink><br /><searchLink fieldCode="DE" term="%22Immune+system%22">Immune system</searchLink><br /><searchLink fieldCode="DE" term="%22Internal+medicine%22">Internal medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Severity+of+illness%22">Severity of illness</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%22">medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Humans%22">Humans</searchLink><br /><searchLink fieldCode="DE" term="%22Lymphocyte+Count%22">Lymphocyte Count</searchLink><br /><searchLink fieldCode="DE" term="%22Interleukin-7+receptor%22">Interleukin-7 receptor</searchLink><br /><searchLink fieldCode="DE" term="%22Interleukin+6%22">Interleukin 6</searchLink><br /><searchLink fieldCode="DE" term="%22Aged%22">Aged</searchLink><br /><searchLink fieldCode="DE" term="%22Interleukin-6%22">Interleukin-6</searchLink><br /><searchLink fieldCode="DE" term="%22SARS-CoV-2%22">SARS-CoV-2</searchLink><br /><searchLink fieldCode="DE" term="%22business%2Eindustry%22">business.industry</searchLink><br /><searchLink fieldCode="DE" term="%22IP-10%2C+Interferon+gamma-induced+protein+10%22">IP-10, Interferon gamma-induced protein 10</searchLink><br /><searchLink fieldCode="DE" term="%22TNF%2C+Tumor+necrosis+factor%22">TNF, Tumor necrosis factor</searchLink><br /><searchLink fieldCode="DE" term="%22COVID-19%22">COVID-19</searchLink><br /><searchLink fieldCode="DE" term="%22NK+cells%2C+Natural+killer+cells%22">NK cells, Natural killer cells</searchLink><br /><searchLink fieldCode="DE" term="%22030104+developmental+biology%22">030104 developmental biology</searchLink><br /><searchLink fieldCode="DE" term="%22biology%2Eprotein%22">biology.protein</searchLink><br /><searchLink fieldCode="DE" term="%22business%22">business</searchLink><br /><searchLink fieldCode="DE" term="%22CD8%22">CD8</searchLink><br /><searchLink fieldCode="DE" term="%22030215+immunology%22">030215 immunology</searchLink> ) Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => To discover immune factors that can predict the progression of COVID-19, we evaluated circulating immune cells and plasma cytokines in COVID-19 patients. We found that T cells, including CD4+ T cells and CD8+ T cells, were significantly decreased in severe COVID-19 symptoms but not in mild symptoms, in comparison with healthy people. T cells remained at a low level after recovery from severe COVID-19. CD4+CD25+CD127low Treg-enriched cells were significantly increased in either mild or severe COVID-19 patients, regardless of recovery or not. Moreover, in either mild or severe COVID-19 patients, Treg-enriched cells up-regulated CD25 and down-regulated CD127. After recovery, CD25 was partially down-regulated but still higher than the normal level, while CD127 returned to the normal level in mild patients but not severe patients. B cells were decreased in mild patients and further decreased in severe patients, and remained low after recovery. NK cells were decreased only in severe COVID-19, with a tendency to return to the normal level after recovery. Plasma IL-6 and IL-10 were both elevated in severe patients but not in mild patients. After recovery, IL-6 remained higher than its normal level, while IL-10 returned to the normal level. Binary logistic regression analysis indicated that CD4+ T cells, B cells, IL-6, and IL-10 were significantly associated with COVID-19 severity. Therefore, these parameters are indicators of COVID-19 severity. Dynamic monitoring of these parameters would benefit therapy planning and prognosis evaluation. ) Array ( [Name] => ISSN [Label] => ISSN [Group] => ISSN [Data] => 0198-8859 ) Array ( [Name] => URL [Label] => Access URL [Group] => URL [Data] => <link linkTarget="URL" linkTerm="https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3a70e9df0e9f88464b7539e60bc6d2c" linkWindow="_blank">https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3a70e9df0e9f88464b7539e60bc6d2c</link><br /><link linkTarget="URL" linkTerm="https://doi.org/10.1016/j.humimm.2020.08.006" linkWindow="_blank">https://doi.org/10.1016/j.humimm.2020.08.006</link> ) Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => OPEN ) Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsair.doi.dedup.....a3a70e9df0e9f88464b7539e60bc6d2c ) |
RecordInfo |
Array
(
[BibEntity] => Array
(
[Languages] => Array
(
[0] => Array
(
[Text] => Undetermined
)
)
[PhysicalDescription] => Array
(
[Pagination] => Array
(
[PageCount] => 7
[StartPage] => 702
)
)
[Subjects] => Array
(
[0] => Array
(
[SubjectFull] => Male
[Type] => general
)
[1] => Array
(
[SubjectFull] => 0301 basic medicine
[Type] => general
)
[2] => Array
(
[SubjectFull] => G-CSF, Granulocyte colony-stimulating factor
[Type] => general
)
[3] => Array
(
[SubjectFull] => Severity of Illness Index
[Type] => general
)
[4] => Array
(
[SubjectFull] => T-Lymphocytes, Regulatory
[Type] => general
)
[5] => Array
(
[SubjectFull] => Gastroenterology
[Type] => general
)
[6] => Array
(
[SubjectFull] => MCP-1, Monocyte chemoattractant protein-1
[Type] => general
)
[7] => Array
(
[SubjectFull] => 0302 clinical medicine
[Type] => general
)
[8] => Array
(
[SubjectFull] => Immunology and Allergy
[Type] => general
)
[9] => Array
(
[SubjectFull] => IL, Interleukin
[Type] => general
)
[10] => Array
(
[SubjectFull] => IL-2 receptor
[Type] => general
)
[11] => Array
(
[SubjectFull] => B-Lymphocytes
[Type] => general
)
[12] => Array
(
[SubjectFull] => COVID-19, Coronavirus disease 2019
[Type] => general
)
[13] => Array
(
[SubjectFull] => biology
[Type] => general
)
[14] => Array
(
[SubjectFull] => Th1, T helper 1
[Type] => general
)
[15] => Array
(
[SubjectFull] => Immune cells
[Type] => general
)
[16] => Array
(
[SubjectFull] => EDTA, Ethylenediaminetetraacetic acid
[Type] => general
)
[17] => Array
(
[SubjectFull] => General Medicine
[Type] => general
)
[18] => Array
(
[SubjectFull] => Middle Aged
[Type] => general
)
[19] => Array
(
[SubjectFull] => Prognosis
[Type] => general
)
[20] => Array
(
[SubjectFull] => PBS, Phosphate-buffered saline
[Type] => general
)
[21] => Array
(
[SubjectFull] => WBC, White blood cells
[Type] => general
)
[22] => Array
(
[SubjectFull] => Interleukin-10
[Type] => general
)
[23] => Array
(
[SubjectFull] => Up-Regulation
[Type] => general
)
[24] => Array
(
[SubjectFull] => IFN, Interferon
[Type] => general
)
[25] => Array
(
[SubjectFull] => Th2, T helper 2
[Type] => general
)
[26] => Array
(
[SubjectFull] => Killer Cells, Natural
[Type] => general
)
[27] => Array
(
[SubjectFull] => Interleukin 10
[Type] => general
)
[28] => Array
(
[SubjectFull] => Cytokines
[Type] => general
)
[29] => Array
(
[SubjectFull] => Female
[Type] => general
)
[30] => Array
(
[SubjectFull] => medicine.symptom
[Type] => general
)
[31] => Array
(
[SubjectFull] => Research Article
[Type] => general
)
[32] => Array
(
[SubjectFull] => Adult
[Type] => general
)
[33] => Array
(
[SubjectFull] => China
[Type] => general
)
[34] => Array
(
[SubjectFull] => medicine.medical_specialty
[Type] => general
)
[35] => Array
(
[SubjectFull] => MIP-1A, Macrophage inflammatory protein 1 alpha
[Type] => general
)
[36] => Array
(
[SubjectFull] => Immunology
[Type] => general
)
[37] => Array
(
[SubjectFull] => NKT cells, Natural killer T cells
[Type] => general
)
[38] => Array
(
[SubjectFull] => Inflammation
[Type] => general
)
[39] => Array
(
[SubjectFull] => Tregs, Regulatory T cells
[Type] => general
)
[40] => Array
(
[SubjectFull] => macromolecular substances
[Type] => general
)
[41] => Array
(
[SubjectFull] => 03 medical and health sciences
[Type] => general
)
[42] => Array
(
[SubjectFull] => Immune system
[Type] => general
)
[43] => Array
(
[SubjectFull] => Internal medicine
[Type] => general
)
[44] => Array
(
[SubjectFull] => Severity of illness
[Type] => general
)
[45] => Array
(
[SubjectFull] => medicine
[Type] => general
)
[46] => Array
(
[SubjectFull] => Humans
[Type] => general
)
[47] => Array
(
[SubjectFull] => Lymphocyte Count
[Type] => general
)
[48] => Array
(
[SubjectFull] => Interleukin-7 receptor
[Type] => general
)
[49] => Array
(
[SubjectFull] => Interleukin 6
[Type] => general
)
[50] => Array
(
[SubjectFull] => Aged
[Type] => general
)
[51] => Array
(
[SubjectFull] => Interleukin-6
[Type] => general
)
[52] => Array
(
[SubjectFull] => SARS-CoV-2
[Type] => general
)
[53] => Array
(
[SubjectFull] => business.industry
[Type] => general
)
[54] => Array
(
[SubjectFull] => IP-10, Interferon gamma-induced protein 10
[Type] => general
)
[55] => Array
(
[SubjectFull] => TNF, Tumor necrosis factor
[Type] => general
)
[56] => Array
(
[SubjectFull] => COVID-19
[Type] => general
)
[57] => Array
(
[SubjectFull] => NK cells, Natural killer cells
[Type] => general
)
[58] => Array
(
[SubjectFull] => 030104 developmental biology
[Type] => general
)
[59] => Array
(
[SubjectFull] => biology.protein
[Type] => general
)
[60] => Array
(
[SubjectFull] => business
[Type] => general
)
[61] => Array
(
[SubjectFull] => CD8
[Type] => general
)
[62] => Array
(
[SubjectFull] => 030215 immunology
[Type] => general
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Characteristics of immune cells and cytokines in patients with coronavirus disease 2019 in Guangzhou, China
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Ying Huang
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Jiabin Chen
)
)
)
[2] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Xiaowen Jiang
)
)
)
[3] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Yaling Shi
)
)
)
[4] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Jide Huang
)
)
)
[5] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Yingyi Huang
)
)
)
[6] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Xing Chen
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 01
[M] => 12
[Type] => published
[Y] => 2020
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-print
[Value] => 01988859
)
[1] => Array
(
[Type] => issn-locals
[Value] => edsair
)
[2] => Array
(
[Type] => issn-locals
[Value] => edsairFT
)
)
[Numbering] => Array
(
[0] => Array
(
[Type] => volume
[Value] => 81
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Human Immunology
[Type] => main
)
)
)
)
)
)
)
|
IllustrationInfo |